Disease/Infection News

RSS

New research could lead to cheaper, easier production of malaria drug artemisinin

"Artemisinin, a crucial drug in the global fight against malaria, could soon become cheaper and easier to make, thanks to researchers who have found a better way to synthesize the compound," Science NOW reports, providing an overview of the research published in Angewandte Chemie on Monday.

20 Jan 2012

About half of eligible and due services are missed during PHEs

More than 20 percent of U.S. adults receive periodic health examinations (PHE) each year, yet new research shows that patients who have an annual routine visit to their doctor may not receive recommended preventive screening tests and counseling services that could benefit their health.

20 Jan 2012

Antimicrobial impregnated scrubs effective in reducing MRSA

The use of antimicrobial impregnated scrubs combined with good hand hygiene is effective in reducing the burden of Methicillin-Resistant Staphylococcus Aureus (MRSA) on healthcare workers' apparel and may potentially play a role in decreasing the risk of MRSA transmission to patients, according to a new study from Virginia Commonwealth University researchers.

20 Jan 2012

Harare maternity clinics reportedly conducting compulsory HIV/AIDS tests on pregnant women

"In a move that is likely to raise the ire of HIV/AIDS activists, maternity clinics in Harare are conducting compulsory HIV/AIDS tests on pregnant women before they can register for delivery," the Zimbabwean reports, adding, "Scores of pregnant women in the high-density suburb of Glen-Norah told this newspaper that they were being asked to bring their spouses to be tested if they wanted to register to deliver their babies."

19 Jan 2012

Georgetown professors explore balance of national security and scientific freedom

The U.S. government's request that the journals Science and Nature withhold scientific information related to the genetically modified H5N1 virus because of biosecurity concerns does not violate the First Amendment, say two Georgetown University professors. They caution, however, that a fair, transparent process undertaken by research organizations is preferable to governmental constraints on disseminating scientific information.

19 Jan 2012

New vaccine for deadly meningococcus B

A new study shows that a new 4-component meningococcal (4CMenB) vaccine for teenagers is effective when administered on a schedule of 2 doses from 1 to 6 months apart. María Elena Santolaya, from the Department of Pediatrics, University of Chile, Santiago, and colleagues performed the study, which was published online January 18 in the Lancet.

19 Jan 2012

New AACN Practice Alert on catheter-associated urinary tract infections

Urinary tract infections account for nearly 40 percent of hospital-acquired infections in acute care hospitals, triggering increased hospital costs and higher patient morbidity and mortality rates. Compounding the toll of these infections, Medicaid, Medicare and many other payers no longer reimburse costs related to treatment because of their presumed preventability.

19 Jan 2012

Study demonstrates possibility of curing hepatitis C without use of interferon

Bristol-Myers Squibb Company today announced the full results, published in the New England Journal of Medicine, from a Phase II clinical trial in patients with hepatitis C virus (HCV) genotype 1 who had not responded to prior therapy with PEG-interferon alfa and ribavirin ('null responders').

19 Jan 2012

Aspirin may benefit HIV-infected women at risk of cervical cancer

Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women.

19 Jan 2012

The AJMS publishes updates on type 2 diabetes, STIs

Research is leading to new insights on two major public health challenges: preventing the spread of sexually transmitted infections (STIs) and improving disease control for patients with type 2 diabetes. Expert updates on these critical topics appear in a special symposium section of the January issue of The American Journal of the Medical Sciences (The AJMS), official journal of the Southern Society for Clinical Investigation.

19 Jan 2012

Community health workers vital to improving health care in Africa

Community health workers (CHWs) "are seen to be a key part of a functioning primary health system," especially in African nations, Jeffrey Sachs, director of the Earth Institute at Columbia University, writes in a post on Huffington Post's "Impact" blog.

19 Jan 2012

New York Times examines history of malaria drug artemisinin

The New York Times examines the history of the Chinese drug artemisinin, "hailed as one of the greatest advances in fighting malaria ... since the discovery of quinine centuries ago," noting the drug "is being talked about as a candidate for a Nobel Prize in Medicine."

19 Jan 2012

Assessing the cost of polio eradication efforts

"After more than a century as a global scourge and hundreds of thousands lives lost, polio may now be on the verge of being the second human disease wiped off the face of the Earth," Charles Kenny, senior fellow at the Center for Global Development, writes in his column for ForeignPolicy.com, "The Optimist."

19 Jan 2012

Risks of modifying flu strains to become highly transmissible in humans outweigh benefits

In this Journal Sentinel Online opinion piece, Thomas Inglesby, chief executive officer and director of the Center for Biosecurity of UPMC in Baltimore; Anita Cicero, chief operating officer and deputy director of the center; and D.A. Henderson, a distinguished scholar at the center, comment on a recent announcement by scientists that they have genetically modified a strain of H5N1 bird flu that is "capable of spreading through the air between ferrets that were physically separated from each other," indicating "it would be readily transmissible by air between humans."

19 Jan 2012

NGOs in Balkan countries to establish regional body to fight HIV/AIDS stigma, discrimination

Agence France-Presse reports that a group of non-governmental organizations (NGOs) is working to establish a regional association to combat HIV/AIDS stigma and discrimination that is prevalent in the Balkan countries.

19 Jan 2012

USAID's worldwide polio eradication coordinator addresses India's polio progress, global efforts

GlobalPost's "Global Pulse" blog interviews Ellyn Ogden, USAID's worldwide polio eradication coordinator since 1997, about India's progress in eradicating polio as it marked one year without a confirmed case and discusses what the overall eradication fight looks like today.

19 Jan 2012

New combo drug helps suppress hepatitis C genotype 1 infection

A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.

19 Jan 2012

PfSET10 molecule plays a crucial role in malaria infection

The discovery by researchers from the Walter and Eliza Hall Institute of a molecule that is key to malaria's 'invisibility cloak' will help to better understand how the parasite causes disease and escapes from the defenses mounted by the immune system.

19 Jan 2012

Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.

19 Jan 2012

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Viread in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12.

19 Jan 2012

Disease/Infection News

New research could lead to cheaper, easier production of malaria drug artemisinin

About half of eligible and due services are missed during PHEs

Antimicrobial impregnated scrubs effective in reducing MRSA

Harare maternity clinics reportedly conducting compulsory HIV/AIDS tests on pregnant women

Georgetown professors explore balance of national security and scientific freedom

New vaccine for deadly meningococcus B

New AACN Practice Alert on catheter-associated urinary tract infections

Study demonstrates possibility of curing hepatitis C without use of interferon

Aspirin may benefit HIV-infected women at risk of cervical cancer

The AJMS publishes updates on type 2 diabetes, STIs

Community health workers vital to improving health care in Africa

New York Times examines history of malaria drug artemisinin

Assessing the cost of polio eradication efforts

Risks of modifying flu strains to become highly transmissible in humans outweigh benefits

NGOs in Balkan countries to establish regional body to fight HIV/AIDS stigma, discrimination

USAID's worldwide polio eradication coordinator addresses India's polio progress, global efforts

New combo drug helps suppress hepatitis C genotype 1 infection

PfSET10 molecule plays a crucial role in malaria infection

Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News